Levocetirizine Dihydrochloride

Product NDC: 61442-460
11-digit product format: 614420460
Labeler code: 61442
Product ID: 61442-460_2e47680c-c285-02ce-e054-00144ff88e88
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Levocetirizine Dihydrochloride
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Carlsbad Technology, Inc.
Application: ANDA203646
Marketing category: ANDA
Marketing start: 2015-11-11
Marketing end: 0000-00-00
Substance: LEVOCETIRIZINE DIHYDROCHLORIDE
Active strength: 5 mg/1
Pharmacologic classes: Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	61442-460		D	Discontinued by firm		2026-08-07
excluded package	package	61442-460	61442-460-90	D	Discontinued by firm		2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 30 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61442-460-90	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61442-460-90	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61442-460-90	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61442-460-90	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61442-460-90	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61442-460-90	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61442-460-90	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61442-460-90	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61442-460-90	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	61442-460-90	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	61442-460-90	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	61442-460-90	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	61442-460-90	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	61442-460-90	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	61442-460-90	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB		2014-09-09

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A203646-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A203646-001	LEVOCETIRIZINE DIHYDROCHLORIDE	5MG	TABLET / ORAL	AB	2014-09-09	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A203646-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203646-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203646-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203646-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203646-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203646-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203646-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203646-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203646-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A203646-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203646-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203646-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203646-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A203646-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203646-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A203646-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A203646-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A203646-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A203646-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A203646-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A203646-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A203646-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A203646-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A203646-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A203646-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A203646-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A203646-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A203646-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A203646-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A203646-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A203646-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A203646-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A203646-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A203646-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A203646-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A203646-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A203646-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A203646-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A203646-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A203646-001	AB	1	`cb3db0bc1861…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
61442-460-90	2022-03-22	C162847	48780-1	9d75b9d0-8afd-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use levocetirizine dihydrochloride tablets safely and effectively. See full prescribing information for levocetirizine dihydrochloride tablets. LEVOCETIRIZINE dihydrochloride tablets for oral use. Initial U.S. Approval: 1995
61442-460-90	2020-01-31	C162847	48780-1	9d75b9d0-8afd-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use levocetirizine dihydrochloride tablets safely and effectively. See full prescribing information for levocetirizine dihydrochloride tablets. LEVOCETIRIZINE dihydrochloride tablets for oral use. Initial U.S. Approval: 1995

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
61442-460-90	EA - Each	61442-460	1e3ab3e8-70aa-44ae-ac49-474e15ed2df6	1	2016-02-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LEVOCETIRIZINE DIHYDROCHLORIDE	ACTIVE INGREDIENT	SOD6A38AGA	LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [CARLSBAD TECHNOLOGY, INC.]	3
LEVOCETIRIZINE	ACTIVE MOIETY	6U5EA9RT2O	LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [CARLSBAD TECHNOLOGY, INC.]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [CARLSBAD TECHNOLOGY, INC.]	3
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [CARLSBAD TECHNOLOGY, INC.]	3
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [CARLSBAD TECHNOLOGY, INC.]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [CARLSBAD TECHNOLOGY, INC.]	3
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [CARLSBAD TECHNOLOGY, INC.]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [CARLSBAD TECHNOLOGY, INC.]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LEVOCETIRIZINE DIHYDROCHLORIDE TABLET, FILM COATED [CARLSBAD TECHNOLOGY, INC.]	3

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 16 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Bryant Ranch Prepack	8274ca80-e7d3-4f4f-9901-cc5c589b4fef	2026-05-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203646 application number: ANDA203646
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Bryant Ranch Prepack	be58ca52-ab5d-4656-bfe0-bd5766235968	2026-05-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203646 application number: ANDA203646
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Bryant Ranch Prepack	c79d3668-5243-4627-ad2b-cc7c045df120	2026-03-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203646 application number: ANDA203646
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	NuCare Pharmaceuticals,Inc.	c2dbf151-5b3d-5dfb-e053-2995a90a4c19	2026-03-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203646 application number: ANDA203646
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Northwind Health Company, LLC	dae403cd-b6fc-7c50-e053-2995a90a95e3	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203646 application number: ANDA203646
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Golden State Medical Supply, Inc.	163dcce7-4535-a596-e063-6394a90a634f	2025-12-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203646 application number: ANDA203646
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	ScieGen Pharmaceuticals, Inc.	bd7fe481-dfe7-4dfd-aa05-6e2318a9234e	2025-10-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203646 application number: ANDA203646
Levocetirizine Dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Westminster Pharmaceuticals, LLC	85dcd6c0-7fb2-40b3-b07f-93bab169011d	2025-09-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203646 application number: ANDA203646
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Preferred Pharmaceuticals, Inc.	8f308352-5854-409e-8bf7-bc9958cc3c5e	2025-07-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203646 application number: ANDA203646
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	NCS HealthCare of KY, LLC dba Vangard Labs	51d88b2a-d10d-4e7a-b874-98de48069223	2025-02-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203646 application number: ANDA203646
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Bryant Ranch Prepack	4d0a0f8e-b298-46d2-b27d-0bb737507fed	2024-04-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203646 application number: ANDA203646
Levocetirizine Dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Proficient Rx LP	7108ad0a-af1e-4172-b4ba-e5d9aaadfba7	2022-10-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203646 application number: ANDA203646
Levocetirizine Dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Proficient Rx LP	1ceff0e6-1e66-4494-b986-1bd23eb6813e	2022-03-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203646 application number: ANDA203646
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Proficient Rx LP	b84ccb27-9c52-43b9-9a46-8f52a571045e	2019-11-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203646 application number: ANDA203646
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Bryant Ranch Prepack	34541530-ae3b-4247-b08c-cd1c13e2e6a1	2019-06-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203646 application number: ANDA203646
levocetirizine dihydrochloride	LEVOCETIRIZINE DIHYDROCHLORIDE	Vensun Pharmaceuticals, Inc.	7a2ca8aa-ba0b-45b4-bdb3-651879350130	2018-07-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203646 application number: ANDA203646

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
SOD6A38AGA	LEVOCETIRIZINE DIHYDROCHLORIDE	130018-87-0	LEVOCETIRIZINE DIHYDROCHLORIDE

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Levocetirizine Dihydrochloride	Carlsbad Technology, Inc. \| ScieGen	2016-03-17	HUMAN PRESCRIPTION DRUG LABEL	7